• Preparation of Added Therapeutic Value dossier, according to the requirements described
by Decree-Law No. 97/2015, of June 1st
• Health technology assessment and reimbursement submissions
• Follow-up throughout the evaluation process, including response to the evaluators
• Personal accompaniment in meetings with INFARMED, I.P.
• Providing opinion and advice on strategic decisions